ICON plc’s Post

Many of the challenges facing CAR T-cell therapies remain unresolved. Recent advancements in engineering CAR T cells with novel functionalities like logic-gating are helping to evolve the field. Our article highlights key challenges and opportunities in CAR T-cell clinical development. Learn more. https://ow.ly/S8EK50RuJHZ

TOMORROW at 12 PM ET! Don't miss this engaging discussion on the intricacies of in vitro diagnostics with Young Wang, MD, and Ingela Mauritzon, PhD. This live webinar addresses the pressing need for standardized regulatory practices in the field of IVDs as advancements are made in an increasingly interconnected global healthcare landscape and demand grows for more precise diagnostics. Enroll now (with or without contact hours) > https://bit.ly/3RV3Sm5 #ACRP #Webinar #ContinuingEducation #InVitroDiagnostics #IVD

In #RareDisease trials, every patient, and every image matters. Learn how Calyx’s proven processes, broad #respiratory experience, and scientific expertise delivered reliable #MedicalImaging data to support regulatory approval of a novel #IPF compound. https://lnkd.in/gtyD2zwc #IdiopathicPulmonaryFibrosis #ClinicalTrials #ChooseCalyx

On their “Getting Ready for the New Regulations” webpage (https://lnkd.in/ggX4WNWD), the European Commission announced they are conducting a survey to understand the communication needs of companies directly affected by the Medical Device Regulation and the In Vitro Diagnostic Regulation (#MDR and #IVDR). Consider taking the survey as the results may provide the Commission with insights to improve communication with stakeholders and provide an opportunity for greater knowledge sharing as we continue to implement the requirements of the new #MDR and #IVDR.  https://lnkd.in/gpvrKnGv #EuropeanCommission #IVD #feedback #survey

🚀 Elevate Your Knowledge: Join our webinar "Considerations for Navigating ISO 22442-3 Viral Inactivation Studies" Delve into the intricacies of medical devices using preclinical model tissues and their derivatives with NAMSA's experts! Key Discussion Points: - Various applications of preclinical model tissues in medical devices - The critical need for viral inactivation testing - Customizing studies and overcoming associated challenges - Molecular screening and batch release considerations Don't miss out on crucial insights! Save your spot now. 📆👉https://lnkd.in/emn6wQfN #MedicalDevices #ISO22442 #ViralInactivation #RegulatoryCompliance #NAMSAknows

I invite you to the NAMSA webinar for insights surrounding ISO 22442-3. Bring your questions for the open Q&A session for answers from our industry leading experts - see you there!

🚀 Elevate Your Knowledge: Join our webinar "Considerations for Navigating ISO 22442-3 Viral Inactivation Studies" Delve into the intricacies of medical devices using preclinical model tissues and their derivatives with NAMSA's experts! Key Discussion Points: - Various applications of preclinical model tissues in medical devices - The critical need for viral inactivation testing - Customizing studies and overcoming associated challenges - Molecular screening and batch release considerations Don't miss out on crucial insights! Save your spot now. 📆👉 https://lnkd.in/emn6wQfN #MedicalDevices #ISO22442 #ViralInactivation #RegulatoryCompliance #NAMSAknows

Are you involved in the medical device sector? Want to stay ahead of the curve with the latest regulatory updates? Join our upcoming webinar, where industry experts will delve into the recent extensions to the In Vitro Diagnostic Regulation (IVDR) and what they mean for you. #IVDR #webinar

🚀 Elevate Your Knowledge: Join our webinar "Considerations for Navigating ISO 22442-3 Viral Inactivation Studies" Delve into the intricacies of medical devices using preclinical model tissues and their derivatives with NAMSA's experts! Key Discussion Points: - Various applications of preclinical model tissues in medical devices - The critical need for viral inactivation testing - Customizing studies and overcoming associated challenges - Molecular screening and batch release considerations Don't miss out on crucial insights! Save your spot now. 📆👉https://lnkd.in/emn6wQfN #MedicalDevices #ISO22442 #ViralInactivation #RegulatoryCompliance #NAMSAknows

🚀 Elevate Your Knowledge: Join our webinar "Considerations for Navigating ISO 22442-3 Viral Inactivation Studies" Delve into the intricacies of medical devices using preclinical model tissues and their derivatives with NAMSA's experts! Key Discussion Points: - Various applications of preclinical model tissues in medical devices - The critical need for viral inactivation testing - Customizing studies and overcoming associated challenges - Molecular screening and batch release considerations Don't miss out on crucial insights! Save your spot now. 📆👉https://lnkd.in/emn6wQfN #MedicalDevices #ISO22442 #ViralInactivation #RegulatoryCompliance #NAMSAknows